Studies on Disease-Modifying Antirheumatic Drugs: Synthesis of Novel Quinoline and Quinazoline Derivatives and Their Anti-inflammatory EffectAtsuo Baba, Takashi Sohda, Shigehisa Taketomi et al.|Journal of Medicinal Chemistry|1996Cited by 151
Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonistsSatoshi Yamamoto, Mitsuhiro Ito, Naoki Tomita et al.|Bioorganic & Medicinal Chemistry|2012Cited by 28
Immunomodulating and articular protecting activities of a new anti-rheumatic drug, TAK-603Yoshikazu Ohta, Haruhiko Makino, Ryoichi Tsukuda et al.|Immunopharmacology|1996Cited by 14
Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonistsSatoshi Yamamoto, Mitsuhiro Ito, Atsushi Hasuoka et al.|Bioorganic & Medicinal Chemistry|2012Cited by 9
Studies on Disease-Modifying Antirheumatic Drugs. II. Synthesis and Activity of the Metabolites of Ethyl 4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603).Atsuo Baba, Takashi Sohda, Haruhiko Makino et al.|Chemical and Pharmaceutical Bulletin|1998Cited by 6